Cargando…

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer

INTRODUCTION: Gastric cancer (GC)is the third leading cause of cancer-related deaths in China and immunotherapy emerging as a revolutionary treatment for GC recently. Tumor mutational burden (TMB) is a predictive biomarker of immunotherapy in multiple cancers. However, the prognostic significance an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yanan, Bu, Dechao, Zhang, Qiaoling, Sun, Rebecca, Lyle, Stephen, Zhao, Gang, Dong, Li, Li, Hui, Zhao, Yi, Yu, Jinpu, Hao, Xishan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491970/ https://www.ncbi.nlm.nih.gov/pubmed/36351537 http://dx.doi.org/10.1016/j.jare.2022.10.019

Ejemplares similares

Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer
por: Zhao, Yan, et al.
Publicado: (2023)

Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
por: Merino, Diana M, et al.
Publicado: (2020)

TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
por: Liang, Hongling, et al.
Publicado: (2021)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023)

Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB
por: Sung, Meng-Ta, et al.
Publicado: (2022)

TMB in NSCLC: A Broken Dream?
por: Bravaccini, Sara, et al.
Publicado: (2021)

Concurrent somatic mutations in driver genes were significantly correlated with lymph node metastasis and pathological types in solid tumors
por: Cheng, Yanan, et al.
Publicado: (2017)

Identifying Inconsistencies and Reporting Deficits in Therapeutic Massage and Bodywork (TMB) Case Reports Authored by TMB Practitioners: a TMB-Adapted CAse REport (CARE) Guidelines Audit Through 2014
por: Munk, Niki, et al.
Publicado: (2016)

Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma
por: Gu, Weiquan, et al.
Publicado: (2020)

Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors
por: Friedlaender, Alex, et al.
Publicado: (2020)

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
por: Yan, Dan, et al.
Publicado: (2021)

MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method
por: Li, Zhengtian, et al.
Publicado: (2021)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Implementing TMB measurement in clinical practice: considerations on assay requirements
por: Büttner, Reinhard, et al.
Publicado: (2019)

Genomic Instability in Cerebrospinal Fluid Cell-Free DNA Predicts Poor Prognosis in Solid Tumor Patients with Meningeal Metastasis
por: Wang, Peng, et al.
Publicado: (2022)

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

The Fabrication of Amino Acid Incorporated Nanoflowers with Intrinsic Peroxidase-like Activity and Its Application for Efficiently Determining Glutathione with TMB Radical Cation as Indicator
por: Jiang, Ning, et al.
Publicado: (2021)

Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis
por: Bu, Luping, et al.
Publicado: (2021)

TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

New methodology of TMB assessment from tissue and liquid biopsy in NSCLC
por: Křížová, Ľudmila, et al.
Publicado: (2022)

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
por: Tang, Yun-Qiang, et al.
Publicado: (2020)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
por: Wei, Jiayan, et al.
Publicado: (2021)

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
por: Jiang, Shan, et al.
Publicado: (2023)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

A Magnetoelectrochemical Bioassay for Highly Sensitive Sensing of Point Mutations in Interleukin-6 Gene Using TMB as a Hybridization Intercalation Indicator
por: Baachaoui, Sabrine, et al.
Publicado: (2023)

ecTMB: a robust method to estimate and classify tumor mutational burden
por: Yao, Lijing, et al.
Publicado: (2020)

Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance
por: Ma, Jincheng, et al.
Publicado: (2022)

PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy
por: Li, Xiangmei, et al.
Publicado: (2023)

The relationship between different subtypes of KRAS and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patients
por: Yang, Ying, et al.
Publicado: (2022)

Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients
por: Feng, Dechao, et al.
Publicado: (2023)

Comprehensive Characterization of 10,571 Mouse Large Intergenic Noncoding RNAs from Whole Transcriptome Sequencing
por: Luo, Haitao, et al.
Publicado: (2013)

Shape dependency of gold nanorods through TMB(2+)-mediated etching for the visual detection of NT-proBNP
por: Jiang, Chenlong, et al.
Publicado: (2023)

The Greater Value of the CONSORT Statement Guidelines: Guideposts for Designing and Reporting all TMB Research
por: Porcino, Antony J.
Publicado: (2012)

TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
por: Hodi, F. Stephen, et al.
Publicado: (2021)

Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy
por: Miao, Ya-Ru, et al.
Publicado: (2022)

The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnq6ectu6ok5nh6ce4i55j90p7